Nektar: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Monday reported a loss of $42.1 million in its fourth quarter.

On a per-share basis, the San Francisco-based company said it had a loss of 22 cents.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.

The biopharmaceutical company posted revenue of $23.9 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $17.1 million.

For the year, the company reported a loss of $276.1 million, or $1.45 per share. Revenue was reported as $90.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NKTR at https://www.zacks.com/ap/NKTR

Advertisement

Recommended Stories